Eating in the GLP-1 era: What’s worth the bite?
As GLP‑1 treatments evolve and usage becomes more sustained - particularly through pill formats - appetite patterns are shifting permanently. Consumers are eating less, choosing differently, and becoming more selective about what food is worth eating at all. For CPGs, this changes the game. As portions shrink, the pressure on every bite increases. Food has to work harder, nutritionally and emotionally. So, what now earns a place in the basket? From protein to fibre, how should brands rethink formulation and portioning as consumer demand fundamentally resets?